The Hymed Group Corporation is pleased to announce that Dr. George Ngwa has joined the company as Director -Strategic Business Development. In this role, Dr. Ngwa will identify new business opportunities to drive organizational growth and increase profits. He will use his extensive experience in R&D, quality (QNQC/RC) and laboratory processing to ensure that The Hymed Group can meet its development goals with minimal setbacks and a successful, strategic plan.

Dr. Ngwa has over 16 years of experience in small, medium, and large pharma/medical device companies with experience in the various phases of product development from conceptualization to commercialization. He has an in-depth knowledge on analytical method development and validation on large and small molecules. He possesses an extensive experience in aseptic processing and other biological methods and processes. He has interacted extensively with the FDA and hosted multiple FDA audits. He has worked in various capacities in different companies such as Particle Sciences, Axcentria Pharmaceuticals, Bbraun and Central Admixture Pharmacy services. His most recent role was Regional Director of Quality for CAPS/Bbraun. He holds a doctorate degree in Pharmaceutical Chemistry from Lehigh University and an MBA in Health Care Management from Western Governors University.

Dr. Ngwa will also be involved in the commercialization and distribution planning for the newest Applied Nutritionals (sister company of Hymed) medical food/nutraceutical product, “Body RepairRX”.

For more information, please see www.hymed.com.